TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $21.90B2017: $21.85B2018: $18.27B2019: $16.89B2020: $16.66B2021: $15.88B2022: $14.93B2023: $15.85B2024: $16.54B2025: $17.26B$17.26B
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$17.26B+4.3%
2024$16.54B+4.4%
2023$15.85B+6.2%
2022$14.93B-6.0%
2021$15.88B-4.7%
2020$16.66B-1.4%
2019$16.89B-7.6%
2018$18.27B-16.4%
2017$21.85B-0.2%
2016$21.90B